| Dec, 17 | Roche and deCODE Announce Milestones in the Pharmacogenomics of Asthma and Hypertension more.. |
| Dec, 15 | Roche reports on two major achievements in Japan, the world´s second largest pharmaceuticals market more.. |
| Dec, 12 | Roche broadens sponsorship of medical care project in South Africa
more.. |
| Dec, 8 | Study of MabThera in aggressive non-Hodgkin´s lymphoma in patients less than 60 years old halted two years early due to significant efficacy benefits more.. |
| Dec, 8 | Breakthrough in Treatment of Indolent Non-Hodgkin´s Lymphoma more.. |
| Dec, 5 | Roche files marketing application for Avastin with European health authorities more.. |
| Nov, 26 | Additional study with Avastin in metastatic colorectal cancer demonstrates a significant increase in progression-free survival more.. |
| Nov, 17 | Roche´s new anaemia drug CERA highly effective in dialysis patients with chronic anaemia
more.. |
| Nov, 13 | Phase III Trial of MabThera for Maintenance Treatment of Indolent non-Hodgkin´s lymphoma (NHL) Halted Early Due to Significant Efficacy Benefits more.. |
| Nov, 10 | Roche licenses promising new antibiotic from Sankyo more.. |
| Nov, 4 | European Approval for Bondronat in major additional indication more.. |
| Oct, 28 | 359 Patient, Phase II Clinical Study Results of MRA, A Beneficial Treatment for Adult Rheumatoid Arthritis more.. |
| Oct, 28 | Pegasys found superior to current hepatitis B treatments more.. |
| Oct, 27 | Phase II clinical study of MRA shows significant clinical benefit to children with systemic-onset Juvenile Idiopathic Arthritis more.. |
| Oct, 27 | Long-term data shows MabThera to be a highly promising treatment for Rheumatoid Arthritis (RA) more.. |
| Oct, 23 | Roche and Nippon Shinyaku enter alliance to develop new medicines to treat cardiovascular disorders more.. |
| Oct, 22 | Unique agreement between Roche and Aspreva to develop CellCept in autoimmune diseases more.. |
| Oct, 21 | Roche acquires rights to diabetes compound from Ipsen more.. |
| Oct, 17 | Roche and deCODE announce discovery of significant genetic risk factors for heart attack more.. |
| Oct, 16 | Dynamic sales growth outpaces global market - Pharmaceuticals growth accelerates further more.. |
| Oct, 9 | Roche builds world´s largest molecular diagnostics manufacturing facility in the US more.. |
| Oct, 1 | Phase III trials of Tarceva plus chemotherapy in lung cancer patients do not meet primary endpoint more.. |
| Sep, 30 | Roche and Protein Design Labs restructure commercial alliance on Zenapax more.. |
| Sep, 23 | Sale of Roche´s Vitamins division to DSM approved by all authorities more.. |
| Sep, 18 | Roche and Memory Expand Strategic Alliance in CNS more.. |
| Sep, 16 | Roche and ParAllele BioScience collaborate to study genetic basis of diabetes more.. |
| Sep, 15 | First Roche Commission goes to composer Sir Harrison Birtwistle more.. |
| Aug, 15 | Roche, the Lucerne Festival and Carnegie Hall launch an intercontinental concert project for contemporary music more.. |
| Jul, 28 | Bondronat for treatment of metastatic bone disease clears important regulatory hurdle in Europe more.. |
| Jul, 24 | Roche to acquire Igen, securing rights to Igen´s ECL-technology more.. |
| Jul, 23 | Half-Year Media Conference more.. |
| Jul, 23 | Roche Group reports successful first half more.. |
| Jul, 22 | Roche expands the strength of its product franchise in Rheumatoid Arthritis and Transplantation more.. |
| Jul, 18 | Roche Researchers Discover Potential New Treatment for Type 2 Diabetes more.. |
| Jul, 15 | Roche SARS test now available more.. |
| Jul, 10 | Court of Appeals reverses punitive damages judgment against Roche in Igen litigation more.. |
| Jul, 8 | Roche Diagnostics opens new headquarters in Spain more.. |
| Jul, 8 | Roche acquires Avastin rights outside the U.S. from Genentech more.. |
| Jun, 25 | Roche Diagnostics Launches the AmpliChip CYP450 in the US, the World´s First Pharmacogenomic Microarray for Clinical Applications more.. |
| Jun, 20 | New trial shows MabThera to be highly effective against rheumatoid arthritis more.. |
| Jun, 2 | Increased potential for cure for people with aggressive blood cancer more.. |
| May, 28 | European Commission approves Fuzeon, first HIV-fusion inhibitor, for use in the fight against HIV more.. |
| May, 23 | Valcyte gains European approval for prevention of CMV Disease following solid organ transplantation more.. |
| May, 23 | Fuzeon approved for marketing and reimbursement in Switzerland more.. |
| May, 22 | Roche and Maxygen establish broad alliance to develop and commercialize next-generation interferon alpha and beta products more.. |
| May, 7 | Management Change in Roche´s Corporate Executive Committee more.. |
| May, 2 | Roche successfully acquires Disetronic more.. |
| Apr, 11 | Roche receives FDA clearance for Cobas Amplicor HIV-1 Monitor Test more.. |
| Apr, 10 | Roche off to a good start in 2003 - first-quarter sales growth up significantly in the Pharmaceuticals Division more.. |
| Apr, 4 | Further progress in safety and environmental protection at Roche - Exhaust-air outlet modifications reduce noise levels at Roche Basel more.. |
| Apr, 3 | European Approval for Use of NeoRecormon Once Every Two Weeks in Renal Anaemia more.. |
| Apr, 2 | Roche donates medicine to Brazilian Government to fight tropical disease more.. |
| Apr, 1 | Roche´s 2003 Annual General Meeting highlights start of a new era more.. |
| Mar, 24 | Commencement of public tender offer to Disetronic shareholders more.. |
| Mar, 20 | EU CPMP Issues Positive Opinion on First HIV Fusion Inhibitor, Fuzeon more.. |
| Mar, 18 | Roche Diagnostics and Epigenomics sign broad Cancer Diagnostics alliance more.. |
| Feb, 26 | Annual Media Conference more.. |
| Feb, 26 | Roche completes realignment around two core businesses and posts strong operating results for 2002; consolidated figures include significant one-time charges more.. |
| Feb, 25 | Roche and Chugai to jointly develop and promote Chugai´s promising new Rheumatoid Arthritis medicine more.. |
| Feb, 24 | European Price Announced for AIDS Drug Fuzeon more.. |
| Feb, 13 | Roche updates pricing policy for protease Inhibitor AIDS Drugs within Accelerating Access Initiative more.. |
| Feb, 10 | Roche completes exit from vitamins business more.. |
| Feb, 10 | Roche expands position in diabetes market - Public tender offer to Disetronic shareholders more.. |
| Jan, 30 | Roche licenses Affymetrix´ GeneChip® Technology more.. |
| Jan, 9 | Roche and deCODE genetics announce identification of significant genetic risk factors for osteoporosis more.. |
| Jan, 8 | Roche, ICN Pharmaceuticals and Ribapharm resolve ribavirin patent dispute more.. |
print this page